Skip to main content
Top

Journal of Radiation Oncology

Issue 3/2019

Content (12 Articles)

Original Research

Challenges in the re-irradiation of locally advanced head and neck cancers: outcomes and toxicities

Christina Phuong, Anthony Pham, Sukhjeet S. Batth, Denice Tsao-Wei, Naomi Schechter, Richard L. Jennelle, Nicholas Trakul, Adam Garsa

Meningioma Original Research

Assessment of the alpha/beta ratio of the optic pathway to adjust hypofractionated stereotactic radiosurgery regimens for perioptic lesions

Herwin Speckter, Jairo Santana, Isidro Miches, Giancarlo Hernandez, Jose Bido, Diones Rivera, Luis Suazo, Santiago Valenzuela, Jazmin Garcia, Peter Stoeter

Original Research

Impact of choice of dose calculation algorithm on PTV and OAR doses in lung SBRT

Kashmiri L. Chopra, Matthew M. Harkenrider, B. Emami, Edward Melian, Jaiteerth S. Avadhani, T. S. Kehwar, D. V. Rai, Anil Sethi

Breast Cancer Original Research

Evaluating improvements in cardiac dosimetry in breast radiotherapy and comparison of cardiac sparing techniques

Ahmad M. Karimi, Martin C. Tom, Bindu V. Manyam, Elizabeth Obi, Rahul D. Tendulkar, Sheen Cherian, Christopher Fleming, Eva Suarez, Mihir Naik, Chirag Shah

Prostate Cancer Original Research

Long-term clinical outcomes of 538 prostate carcinoma patients treated with combination high-dose-rate brachytherapy and external beam radiotherapy

Brandon M. Lehrich, John Ravera, Navid Mostaghni, Jeffrey Yoshida, Robert Torrey, Ruben Baghdassarian, Michael Gazzaniga, Alan Weinberg, Cu Phan, Stuart Chalfin, Lucy Barnes, Albert Mesa, Kenneth Tokita

Metastasis Original Research

Therapeutic value of postmastectomy radiation therapy for T1–2 breast cancer with 1–3 positive lymph nodes

Yuri Kimura, Shinsuke Sasada, Noriko Goda, Keiko Kajitani, Akiko Emi, Norio Masumoto, Takayuki Kadoya, Morihito Okada

Brachytherapy Original Research

Definitive chemoradiation followed by stereotactic body radiotherapy boost for inoperable endometrial cancer

Shraddha M. Dalwadi, Constantine Mantz, Bui Tung, Nabila Waheed, Danny Tran, Mark Bonnen, Michelle Ludwig

Brachytherapy Letter to the Editor

Letter to the Editor concerning “Re-irradiation in gynaecological cancers, present experiences and future hopes”

Amelia Barcellini, Viviana Vitolo, Edoardo Mastella, Alfredo Mirandola, Francesca Valvo

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine